European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn:
“Debate at ESTRO25: Is the promise of AI and mathematical oncology in personalised medicine overhyped?
Experts clashed. Minds changed. Votes shifted.
- From 46% → 41% for the motion
- From 54% → 59% against
More posts featuring ESTRO25.